Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
JAMA Oncol
.
2018 Apr 1;4(4):585.
doi: 10.1001/jamaoncol.2017.0487.
Authors
Takahiro Hasegawa
1
,
Hajime Uno
2
,
Lee-Jen Wei
3
Affiliations
1
Biostatistics Department, Shionogi & Co, Ltd, Osaka, Japan.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
3
Department of Biostatistics, Harvard University, Boston, Massachusetts.
PMID:
29192309
DOI:
10.1001/jamaoncol.2017.0487
No abstract available
Publication types
Comment
MeSH terms
Bone Density Conservation Agents*
Bone and Bones
Breast Neoplasms*
Diphosphonates
Female
Humans
Zoledronic Acid
Substances
Bone Density Conservation Agents
Diphosphonates
Zoledronic Acid